MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2

Title
MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2
Authors
Keywords
Micro-630; Bcl-2; cisplatin; chemotherapy; NSCLC
Journal
Oncotarget
Volume 9, Issue 17, Pages -
Publisher
Impact Journals, LLC
Online
2018-02-12
DOI
10.18632/oncotarget.24474

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now